Drug Shortage Report for ROFACT 300MG

Last updated on 2019-06-18 History
Report ID 65751
Drug Identification Number 00343617
Brand name ROFACT 300MG
Common or Proper name ROFACT 300MG
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C.
Active Ingredient(s) RIFAMPIN
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100's
ATC code J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-05-02
Estimated end date 2019-08-15
Actual end date
Shortage status Actual shortage
Updated date 2019-06-18
Company comments
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v31 2019-06-18 French Compare
v30 2019-06-18 English Compare
v29 2019-06-13 French Compare
v28 2019-06-13 English Compare
v27 2019-06-13 English Compare
v26 2019-06-13 French Compare
v25 2019-06-13 English Compare
v24 2019-06-13 French Compare
v23 2019-06-13 English Compare
v22 2019-06-13 French Compare
v21 2019-06-13 English Compare
v20 2019-06-12 French Compare
v19 2019-06-12 English Compare
v18 2019-06-07 French Compare
v17 2019-06-07 English Compare
v16 2019-05-08 French Compare
v15 2019-05-08 English Compare
v14 2019-04-10 French Compare
v13 2019-04-10 English Compare
v12 2019-04-03 French Compare

Showing 1 to 20 of 31